Clinical Trials · NCT03035032
A Study of ELIGARD® in Hormone-dependent Prostate Cancer Patients
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Astellas Pharma Singapore Pte. Ltd.
- Enrollment
- 107
- Start date
- Jun 2017
- Locations
- 19 sites, 8 countries
- Primary endpoint
- Number of Participants With Eligard Related Adverse Events (AE)